Epsilon Healthcare Limited

As of December 31, 2025, Epsilon Healthcare Limited carries a market capitalization of 12.51M, placing it among publicly traded companies globally. Its enterprise value stands at 22.62M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Epsilon Healthcare Limited has 379.10M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 1.33, and the price-to-book ratio stands at 6.54.

These figures are as of December 31, 2025. The EV/Sales ratio of 2.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 22.62M versus a market cap of 12.51M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, Epsilon Healthcare Limited maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 541.30, indicating elevated leverage, while an interest coverage ratio of -2.24 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -9.03, reflecting losses generated across the asset base. Inventory turnover of 4.19 indicates how many times Epsilon Healthcare Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2025, Epsilon Healthcare Limited recorded an income tax benefit of -966,799.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -2.25M and -1.28M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Epsilon Healthcare Limited's stock has declined approximately 16.67% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.03.

Over the twelve months ended December 31, 2025, Epsilon Healthcare Limited generated 9.39M in revenue and converted that into -1.28M in net income, yielding earnings per share of 0.00. EBITDA reached -2.02M, while operating income came in at -2.38M.

As of December 31, 2025, Epsilon Healthcare Limited holds 242,862.00 in cash and equivalents against 10.35M in total debt, resulting in a net debt position of 4.64M. Total book value stands at 1.91M, with working capital of 765,013.00 providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

Over the twelve months ended December 31, 2025, Epsilon Healthcare Limited posted a gross margin of 61.31, reflecting its pricing power and cost economics. The operating margin of -25.31 and net profit margin of -13.61 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Total shareholder yield reaches 35.83, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Epsilon Healthcare Limited shareholders.

As of December 31, 2025, Epsilon Healthcare Limited has an Altman Z-Score of -3.38, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.